MDHB-517Introduced

Drug Manufacturers - Drug Take-Back Programs (Take It Back Maryland Act)

Jurisdiction:: Maryland
Type:: EPR
Last action:: Mar 17, 2023

Pharmaceuticals

HB-517 establishes a drug manufacturer take-back program requiring producers to fund and operate collection systems for unused medications, a core EPR mechanism shifting end-of-life responsibility to manufacturers.

View Source ↗

Explore more circular-economy legislation on the Atlas Circular legislation tracker.